These authors equally contributed to this work.
Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis
Article first published online: 23 OCT 2009
© 2009 The Authors. Journal compilation © 2009 European Academy of Dermatology and Venereology
Journal of the European Academy of Dermatology and Venereology
Volume 24, Issue 5, pages 607–610, May 2010
How to Cite
Greisenegger, E., Novak, N., Maintz, L., Bieber, T., Zimprich, F., Haubenberger, D., Gleiss, A., Stingl, G., Kopp, T. and Zimprich, A. (2010), Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis. Journal of the European Academy of Dermatology and Venereology, 24: 607–610. doi: 10.1111/j.1468-3083.2009.03469.x
- Issue published online: 9 APR 2010
- Article first published online: 23 OCT 2009
- Received: 9 April 2009; Accepted: 16 September 2009
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.